Development of breast cancer immunotherapy using MUC1 retargeted T lymphocytes

被引：0
|
作者：
S Wilkie
MK Brenner
J Taylor-Papadimitriou
J Burchell
J Maher
机构：
[1] Cancer Research UK Breast Cancer Biology Group,Division of Cancer Studies, Guy's Hospital
[2] Baylor College of Medicine,Center for Cell and Gene Therapy
[3] Texas Children's Hospital,Department of Allergy and Clinical Immunology
[4] King's College Hospital NHS Trust,undefined
来源：
Breast Cancer Research | / 8卷
关键词：
Breast Cancer; Chimeric Antigen Receptor; Breast Tumour Cell; MUC1 Mucin; T47D Breast Cancer Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Development of breast cancer immunotherapy using MUC1 retargeted T lymphocytes
    Wilkie, S.
    Brenner, M. K.
    Taylor-Papadimitriou, J.
    Burchell, J.
    Maher, J.
    [J]. BREAST CANCER RESEARCH, 2006, 8 (Suppl 2) : S17 - S18
  • [2] Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes
    Wilkie, S.
    Picco, G.
    Foster, J.
    Davies, D.
    Julien, S.
    Cooper, L.
    Arif, S.
    Mather, S.
    Taylor-Papadimitriou, J.
    Burchell, J.
    Maher, J.
    [J]. BREAST CANCER RESEARCH, 2008, 10 (Suppl 2) : S4 - S5
  • [3] Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes
    S Wilkie
    G Picco
    J Foster
    D Davies
    S Julien
    L Cooper
    S Arif
    S Mather
    J Taylor-Papadimitriou
    J Burchell
    J Maher
    [J]. Breast Cancer Research, 10
  • [4] Advances of MUC1 as a target for breast cancer immunotherapy
    Yang, E.
    Hu, X. F.
    Xing, P. X.
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 2007, 22 (08) : 905 - 922
  • [5] Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes
    Kondo, Hiroshi
    Hazama, Shoichi
    Kawaoka, Toru
    Yoshino, Shigefumi
    Yoshida, Shin
    Tokuno, Kazuhisa
    Takashima, Motonari
    Ueno, Tomio
    Hinoda, Yuji
    Oka, Masaaki
    [J]. ANTICANCER RESEARCH, 2008, 28 (1B) : 379 - 387
  • [6] Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope
    Heukamp, LC
    van Hall, T
    Ossendorp, F
    Burchell, JM
    Melief, CJM
    Taylor-Papadimitriou, J
    Offringa, R
    [J]. JOURNAL OF IMMUNOTHERAPY, 2002, 25 (01) : 46 - 56
  • [7] MUC1 and breast cancer
    Apostolopoulos, V
    Pietersz, GA
    McKenzie, IFC
    [J]. CURRENT OPINION IN MOLECULAR THERAPEUTICS, 1999, 1 (01) : 98 - 103
  • [8] MUC1 immunotherapy
    Beatson, Richard E.
    Taylor-Papadimitriou, Joyce
    Burchell, Joy M.
    [J]. IMMUNOTHERAPY, 2010, 2 (03) : 305 - 327
  • [9] MUC1 as a target antigen for cancer immunotherapy
    Acres, B
    Limacher, JM
    [J]. EXPERT REVIEW OF VACCINES, 2005, 4 (04) : 493 - 502
  • [10] Tumour immunotherapy against MUC1 expressing tumours using mannan MUC1
    Apostolopoulos, V
    Pietersz, GA
    Acres, B
    Osinski, C
    Thynne, G
    Xing, PX
    Karanikas, V
    Vaughan, HA
    Hwang, L
    Popovski, V
    Lees, C
    Ong, CS
    McKenzie, IFC
    [J]. BREAST CANCER - ADVANCES IN BIOLOGY AND THERAPEUTICS, 1996, : 315 - 320
12345